{"id":"W2074269068","doi":"10.1016/j.cllc.2013.08.001","title":"A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium","year":2013,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal General Hospital; University of Toronto; University of Ottawa; McGill University; Ottawa Hospital","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Internal medicine; Proto-oncogene tyrosine-protein kinase Src; Oncology; Chemotherapy; Cancer; Kinase; Population; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004540753,0.0003922463,0.00120974,0.0001179218,0.0001744632,0.00002017747,0.0003284136,0.0002554953,0.0005278729],"category_scores_gemma":[0.0002573844,0.0002707911,0.0003334868,0.0004862453,0.0004061795,0.0002609597,0.0001463929,0.0004857518,0.000002413402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003704459,"about_ca_system_score_gemma":0.001583605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002705587,"about_ca_topic_score_gemma":0.0005779318,"domain_scores_codex":[0.9962968,0.0002023603,0.001844135,0.00072233,0.0004060037,0.0005284115],"domain_scores_gemma":[0.9968902,0.0003791585,0.001015436,0.0008260576,0.0005295773,0.0003595965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.08350331,0.1432724,0.3732383,0.003025285,0.003598036,0.0001398418,0.009950231,0.0003405046,0.01099554,0.0001338987,0.02422149,0.3475812],"study_design_scores_gemma":[0.8333248,0.07787762,0.03360411,0.004379885,0.007370912,0.000006173316,0.001184329,0.008644429,0.0248713,0.00006690912,0.007353482,0.001315974],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984096,0.00435043,0.00001909367,0.001486982,0.001126604,0.0078368,0.0003528437,0.00005040478,0.0006808487],"genre_scores_gemma":[0.9924846,0.001916663,0.0002924456,0.0004695772,0.0006286303,0.0028999,0.0001735678,0.00006200717,0.001072618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7498215,"threshold_uncertainty_score":0.9999744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02339027935434116,"score_gpt":0.4181057393726841,"score_spread":0.394715460018343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}